Mayinglong Pharmaceutical Group Co Ltd (600993) — Long-term Investment Intensity
Mayinglong Pharmaceutical Group Co Ltd (600993) has a Long-term Investment Intensity of 6.7% as of September 2019. Long-term investments of CN¥222.92 Million represent 6.7% of total assets of CN¥3.31 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check 600993 financial resilience to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Mayinglong Pharmaceutical Group Co Ltd Long-term Investment Intensity (2015–2018)
This chart shows how Mayinglong Pharmaceutical Group Co Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 6.7%, reflecting long-term investments of CN¥222.92 Million against total assets of CN¥3.31 Billion CNY. For the complete balance sheet picture, see 600993 asset base.
Annual Long-term Investment Intensity for Mayinglong Pharmaceutical Group Co Ltd (2015–2018)
The table below presents the year-by-year Long-term Investment Intensity for Mayinglong Pharmaceutical Group Co Ltd from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read how much debt does Mayinglong Pharmaceutical Group Co Ltd carry for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 7.1% | CN¥206.61 Million | CN¥2.93 Billion | ▲ +0.1 pp |
| 2017 | 6.9% | CN¥191.22 Million | CN¥2.75 Billion | ▼ -0.9 pp |
| 2016 | 7.8% | CN¥195.39 Million | CN¥2.50 Billion | ▲ +1.9 pp |
| 2015 | 6.0% | CN¥143.44 Million | CN¥2.41 Billion | — |